https://www.selleckchem.com/pr....oducts/elacridar-gf1
al and echocardiographic surveillance of patients harboring this adverse LV remodeling feature. LVAR was found in ~20% of patients with mild or moderate AS and was not related to the degree of AS severity or concomitant comorbidities, but rather to older age. LVAR was significantly associated with reduced LV longitudinal systolic function, increased Nt-proBNP levels, and higher risk of major adverse events and death. These findings provide support for closer clinical and echocardiographic surveillance of patients harboring th
Beğen
Yorum Yap
Paylaş
